NCT03819621 (OCUPEYE) is a NA clinical trial of IRISS Medical Technologies mediGrid app in Enucleated; Eye, sponsored by Moorfields Eye Hospital NHS Foundation Trust.

Who is sponsoring NCT03819621?

NCT03819621 is sponsored by Moorfields Eye Hospital NHS Foundation Trust.

What drugs are being tested in NCT03819621?

Interventions in NCT03819621: IRISS Medical Technologies mediGrid app.

What condition does NCT03819621 study?

NCT03819621 studies Enucleated; Eye.

Is NCT03819621 still recruiting?

NCT03819621 is currently completed. Last updated 20 August 2020.

Last reviewed 2020-08-20 · How we verify

NCT03819621: OCUPEYE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Digital Imaging Assessment of Ocular Prosthesis Motility

Completed NA Last updated 20 August 2020

What this trial tests

NA trial testing IRISS Medical Technologies mediGrid app in Enucleated; Eye in 57 participants. Completed in 20 August 2019.

Timeline

30 January 2019

Primary endpoint
18 July 2019

20 August 2019

Quick facts

Lead sponsor	Moorfields Eye Hospital NHS Foundation Trust
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	57
Start date	30 January 2019
Primary completion	18 July 2019
Estimated completion	20 August 2019
Sites	1 location across United Kingdom

Drugs / interventions tested

IRISS Medical Technologies mediGrid app

Conditions studied

Enucleated; Eye — all drugs for Enucleated; Eye →

Sponsor

Moorfields Eye Hospital NHS Foundation Trust

Who can join

18 and older, any sex, with Enucleated; Eye. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate the degree of translational movement loss from orbital implant to ocular prosthesis. This will be measured using two software applications - Image J as well as the mediGrid smartphone app in measuring prosthesis motility by comparing it to the ruler as a "gold" standard.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Moorfields Eye Hospital NHS Foundation Trust trials

Trials by the same sponsor.

NCT06974162 — Metagenomics for Ocular Inflammation · recruiting
NCT06689397 — Investigating Epstein-Barr Virus Associated Conjunctivitis · enrolling by invitation
NCT06528509 — AI-Enhanced Consent for Cataract Surgery · NA · not yet recruiting
NCT03102138 — Retinal Pigment Epithelium Safety Study for Patients in B4711001 · active not recruiting
NCT05543889 — Evaluation of Clinical Decisions and Assessment of Those at Risk of Primary Angle Closure by Community Optometrists · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03819621 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Moorfields Eye Hospital NHS Foundation Trust
Last refreshed: 20 August 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03819621.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing